Literature DB >> 1849356

The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study.

P S Randhawa1, R Jaffe, A J Demetris, M Nalesnik, T E Starzl, Y Y Chen, L M Weiss.   

Abstract

The systemic distribution of Epstein-Barr virus (EBV) genomes was studied in paraffin-embedded tissues from 12 fatal cases of Post-transplantation lymphoproliferative disease (PTLD), using an in situ hybridization technique employing an alpha-35S-dCTP-radiolabeled BamHI-W fragment of EBV DNA. The presence of EBV was documented in various PTLD-involved organs. The hybridization signal for the virus localized predominantly in the abnormal lymphoid cells, but signals also were detected in hepatocytes and/or adrenal cortical cells in five cases. The distribution of autoradiographic label within the lymphoid cells was focal and its intensity varied from field to field suggesting a nonuniformity of the viral genomic load in the infected tissues. Recruitment of EBV genome-bearing cells was not observed into inflammatory mononuclear infiltrates found in organs without histopathologic evidence of PTLD.

Entities:  

Mesh:

Year:  1991        PMID: 1849356      PMCID: PMC1886109     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Fatal infectious mononucleosis. Association with liver necrosis and herpes-like virus particles.

Authors:  M Y Chang; W G Campbell
Journal:  Arch Pathol       Date:  1975-04

2.  Epstein-Barr virus genomes in lymphoid cells: activation in mitosis and chromosomal location.

Authors:  C G Teo; B E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.

Authors:  T Takimoto; H Sato; H Ogura; T Miyawaki; R Glaser
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

4.  Human epithelial cell expression of an Epstein-Barr virus receptor.

Authors:  J W Sixbey; D S Davis; L S Young; L Hutt-Fletcher; T F Tedder; A B Rickinson
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

5.  Catalogue of Epstein-Barr virus (EBV) receptors on human malignant and non-malignant hematopoietic cell lines.

Authors:  E Tatsumi; S Harada; C Kuszynski; D Volsky; J Minowada; D T Purtilo
Journal:  Leuk Res       Date:  1985       Impact factor: 3.156

6.  Epstein-Barr virus lymphoproliferation after bone marrow transplantation.

Authors:  M M Zutter; P J Martin; G E Sale; H M Shulman; L Fisher; E D Thomas; D M Durnam
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

7.  The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

Authors:  M A Nalesnik; R Jaffe; T E Starzl; A J Demetris; K Porter; J A Burnham; L Makowka; M Ho; J Locker
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

8.  Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases.

Authors:  B Z Katz; N Raab-Traub; G Miller
Journal:  J Infect Dis       Date:  1989-10       Impact factor: 5.226

9.  Epstein-Barr virus receptors on human pharyngeal epithelia.

Authors:  L S Young; D Clark; J W Sixbey; A B Rickinson
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

10.  Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.

Authors:  M Ho; G Miller; R W Atchison; M K Breinig; J S Dummer; W Andiman; T E Starzl; R Eastman; B P Griffith; R L Hardesty
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

View more
  8 in total

Review 1.  Lymphoproliferative disease in organ transplant recipients.

Authors:  M A Nalesnik
Journal:  Springer Semin Immunopathol       Date:  1991

2.  Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells.

Authors:  A Masih; D Weisenburger; M Duggan; J Armitage; R Bashir; D Mitchell; R Wickert; D T Purtilo
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

3.  Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders.

Authors:  D T Rowe; L Qu; J Reyes; N Jabbour; E Yunis; P Putnam; S Todo; M Green
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders.

Authors:  A P Limaye; M L Huang; E E Atienza; J M Ferrenberg; L Corey
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

5.  Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease.

Authors:  P S Randhawa; R Jaffe; A J Demetris; M Nalesnik; T E Starzl; Y Y Chen; L M Weiss
Journal:  N Engl J Med       Date:  1992-12-10       Impact factor: 91.245

6.  Post-transplant lymphoproliferative disorders.

Authors:  K J Lewin
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

Review 7.  The influence of long-term morbidity on health status and rehabilitation following paediatric organ transplantation.

Authors:  P A Keown; C R Shackleton; B M Ferguson
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

8.  Two cases of post transplant lymphoproliferative disorder in lung transplant recipients.

Authors:  Yoon Soo Chang; Young Kim; Do-Youn Kim; Hyung-Jung Kim; Chul-Min Ahn; Doo-Yun Lee; Hyo-Chae Paik
Journal:  Korean J Intern Med       Date:  2004-12       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.